Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:51:32.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added a new revision tag (Revision: v3.4.2). Removed an operational status notice about government funding, while the study details and status remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T02:33:13.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A new notice warns that information on the site may not be up to date due to a lapse in government funding, with a link to opm.gov for status updates. The page version has been updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:27:19.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The changes include a new 'Show glossary' feature and minor label capitalization updates for entries such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision label updated to 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T21:51:04.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page revision was updated from v3.3.3 to v3.3.4, indicating a minor update to the page content or formatting.
    Difference
    0.1%
    Check dated 2026-01-20T18:51:39.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Locations now includes Greater London, and the page previously listing 'Greater London Locations' has been removed. The footer item 'HHS Vulnerability Disclosure' has been deleted, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:57:10.000Z thumbnail image

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.